Average Co-Inventor Count = 2.24
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aventis Pharma S.a. (10 from 377 patents)
2. Sanofi (5 from 1,455 patents)
3. Aventis Pharma Limited (1 from 39 patents)
16 patents:
1. 9346894 - Polysaccharides comprising two antithrombin III-binding sites, preparation thereof and use thereof as antithrombotic medicaments
2. 8652785 - Method of screening a modulator of endothelial NO synthase comprising the use of heme binding protein 1
3. 8546354 - Acylated decasaccharides and their use as antithrombotic agents
4. 8518909 - Sulfated heptasaccharide and its use as an antithrombotic agent
5. 8501711 - Acylated 1,6-anhydro decasaccharide and its use as an antithrombotic agent
6. 8071570 - Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
7. 8003623 - Mixtures of sulfated oligosaccharides
8. 7956046 - Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
9. 7812007 - Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
10. 7687274 - Method for determining specific groups constituting heparins or low molecular weight heparins
11. 7678766 - Process for the preparation of cyclosporin derivatives
12. 7575930 - Method for analyzing oligosaccharides from blood plasma
13. 7226905 - Process for the preparation of cyclosporin derivatives
14. 6969705 - Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
15. 6617316 - Oligosaccharides, their preparation and pharmaceutical compositions containing them